Droxidopa
compare suppliers & send inquiries for free
Filters
Reset
Selected filters:
Type
Region
Qualifications
Country of origin
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Send inquiry
Replies slower than most
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Send inquiry
Replies slower than most
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Producer
+ 0
All certificates
Send inquiry
Not active
Looking for Droxidopa 23651-95-8?
- Description:
- Here you will find a list of producers, manufacturers and traders of Droxidopa. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Droxidopa
- Synonyms:
- L-Dihydroxyphenylserine , DOPS , L-DOPS , L-threo-dihydroxyphenylserine
- Cas Number:
- 23651-95-8
- DrugBank number:
- DB06262
- Unique Ingredient Identifier:
- J7A92W69L7
About Droxidopa
Here you will find more information about Droxidopa. Droxidopa is a precursor of noradrenaline that is used in the treatment of Parkinsonism. It is approved for use in Japan and is currently in trials in the USA The racaemic form (dl-threo-3-dihydroxyphenylserine) has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopamine in Parkinson's disease and it has been proposed that this underlies the sudden transient freezing seen usually in advanced disease.
Though L-DOPS has been used in Japan and Southeast Asia already for some time, it is also currently in clinical trials at the phase III point in the United States (USA), Canada, Australia, and throughout Europe. Provided L-DOPS successfully completes clinical trials, it could be approved for the treatment of neurogenic orthostatic hypotension (NOH) as early as 2011. Additionally, phase II clinical trials for intradialytic hypotension are also underway. Chelsea Therapeutics obtained orphan drug status (ODS) for L-DOPS in the USA for NOH, and that of which associated with Parkinson's disease , pure autonomic failure, and multiple system atrophy, and is the pharmaceutical company developing it in that country.
Check who is selling Droxidopa in the overview above.
Droxidopa manufacturers | traders | suppliers
We have 5 companies offering Droxidopa from 4 different countries.
Get in contact with the supplier of your choice:
- Quimica Sintetica from Spain
- Lupin from India
- Clarochem from Ireland
- Chongqing Shenghuaxi from China
- MSN Life Sciences from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
